The INFO Project

Johns Hopkins Bloomberg School of Public Health
Español Français Português Population Reports Home Related Resources Contact Us FAQs Site Map Feedback About Population Reports Online Reports Upcoming Reports Press Releases Order
Population Reports Search Population Reports: 
[Or Search POPLINE & other INFOforhealth.org resources]

 

 

 

L Series
Series L, Number 15 Issues in World Health

Family Planning Choices for Women With HIV

How providers can help women with HIV make reproductive decisions

CONTENTS

Home (Key Points)

Supporting the Reproductive Decisions of Women With HIV

Box: Family Planning Is a Key Strategy to Reduce Mother-to-Child Transmission of HIV

Box: When a Woman With HIV Decides About Pregnancy

Box: Helping Women Talk With Their Partners About Contraception and Safer Sex

Box: Information Communication Technology: Mobile Phones Keep Women With HIV in Contact With Care

Women With HIV Can Safely Use Most Contraceptive Methods

Box: Dual Protection Strategies Help Prevent Pregnancy and STIs

Women With HIV Need the Facts About Pregnancy

Box: What People With HIV Need to Know About Pregnancy and
Preventing Pregnancy


Bibliography

Credits

From INFO's Toolbox
INFO Report: “Women and HIV: Questions Answered”
Web Tool: Assess Your Attitudes and Beliefs About People With HIV
Box: What People With HIV Need to Know About Preventing Pregnancy

Quick Look
Table 1: Comparing Contraceptive Methods for People with HIV
Table 2: Drug Interactions: Combined Oral Contraceptives and Antiretroviral (ARV) Medications
Web Box: Condoms at a Glance

OrderOrder this report
DownloadDownload PDF
E-mailE-mail this page
See More Population ReportsSee Companion INFO Report: “Women and HIV: Questions Answered”
See More Population ReportsSee more Population Reports

Quick LookTable 2. Drug Interactions: Combined Oral Contraceptives and Antiretroviral (ARV) Medications

While there is some theoretical concern that ARVs might reduce the effectiveness of combined oral contraceptives (COCs), women taking ARVs can still generally use COCs. Providers can use the table below to guide counseling and prescribing. In general, if a woman using ARVs wants to use COCs, she can be given a formulation with at least 30µg of estrogen, counseled about the importance of taking COCs every day (without missing pills), and encouraged to use condoms consistently. Correct and consistent condom use would help to make up for any decrease in effectiveness of the oral contraceptives as well as help to protect an uninfected sexual partner (195).

ARV

Effect on Contraceptive Hormone Level*

Effect on ARV Level

Protease inhibitors (PIs)

Amprenavir

Increase

Decrease

Atazanavir

Increase

No data

Darunavir

Decrease

No change

Fosamprenavir

Decrease

Decrease

Indinavir

Increase

No data

Lopinavir + Ritonavir

Decrease

No data

Nelfinavir

Decrease

No data

Ritonavir

Decrease

No data

Saquinavir

No change

No change

Tenofovir

No change

No change

Tipranavir

Decrease

Decrease

Non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Delavirdine

May increase

No data

Efavirenz

Increase

No change

Nevirapine

Decrease

No data

*Estrogen levels only
Sources: Adapted from World Health Organization 2004 (248). Additional information from HIV InSite 2007 (90) and U.S. Department of Health and Human Services 2006 (166)


Back to top

Disclaimer: The information provided on this web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development, the U.S. Government or The Johns Hopkins University.